Basics Equillium, Inc. IPO Date: October 8, 2018 Sector: Healthcare Industry: Biotech Market Cap: $13.07M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.66% Avg Daily Range (30 D): $0.01 | 3.42% Avg Daily Range (90 D): $0.03 | 4.40% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 200 Avg Trade Size (Sh.) (30 D): 638 Avg Trade Size (Sh.) (90 D): 488 Institutional Trades Total Inst.Trades: 27 Avg Inst. Trade: $1.31M Avg Inst. Trade (30 D): $.71M Avg Inst. Trade (90 D): $.71M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 179.46K     News Sep 22, 2024 @ 4:30 AM Graft versus Host Disease Market to Increase at a ... Source: Delveinsight Sep 16, 2024 @ 1:00 PM Vivtex Enters New Research Agreement w... Source: N/A May 9, 2024 @ 9:35 PM Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue... Source: Zacks Equity Research May 8, 2024 @ 10:25 PM Alector (ALEC) Reports Q1 Loss, Tops Revenue Estim... Source: Zacks Equity Research Apr 1, 2024 @ 1:52 PM 5 Stocks That More Than Doubled in Q1 With More Ga... Source: Sweta Killa Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.4 $-.24 $-.17 Diluted EPS $-.4 $-.24 $-.17 Revenue $ 30.41M $ M $ 4.39M Gross Profit $ $ $ Net Income / Loss $ -13.99M $ -8.65M $ -5.79M Operating Income / Loss $ -14.35M $ -8.87M $ -4.7M Cost of Revenue $ $ $ Net Cash Flow $ -8.63M $ -3.58M $ 2.77M PE Ratio